NASDAQ:CLMTCalumet Specialty Products Partners, L.P Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Calumet Specialty Products Partners, L.P Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $2.26 +0.13 (+6.10 %) (As of 07/6/2020 09:38 AM ET) Add Compare Share Today's Range$2.20Now: $2.26▼$2.3550-Day Range$1.97MA: $2.56▼$3.2452-Week Range$0.82Now: $2.26▼$5.00Volume27,830 shsAverage Volume142,876 shsMarket Capitalization$176.19 millionP/E RatioN/ADividend YieldN/ABeta3.19 ProfileAnalyst RatingsAdvanced ChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Calumet Specialty Products Partners, L.P. produces and sells specialty hydrocarbon products in North America and internationally. It operates in two segments, Specialty Products and Fuel Products. The Specialty Products segment offers various lubricating oils, white mineral oils, solvents, petrolatums, waxes, synthetic lubricants, and other products which are used primarily as raw material components for basic automotive, industrial, and consumer goods. The Fuel Products segment provides fuel and fuel-related products, including gasoline, diesel, jet fuel, asphalt, and heavy fuel oils, as well as resells purchased crude oil to third party customers. Calumet GP, LLC serves as the general partner for Calumet Specialty Products Partners, L.P. The company was founded in 1916 and is headquartered in Indianapolis, Indiana.Read More Beat the Market (BTM) Rank™ 1.0 Analyst's Opinion Consensus RatingCalumet Specialty Products Partners, L.P has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $1.00, Calumet Specialty Products Partners, L.P has a potential downside of 53.1% from its current price of $2.13.Amount of Analyst CoverageCalumet Specialty Products Partners, L.P has received no research coverage in the past 90 days. Previous Next 1.9 Community Rank Outperform VotesCalumet Specialty Products Partners, L.P has received 285 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCalumet Specialty Products Partners, L.P has received 483 “underperform” votes. (Add your “underperform” vote.)Community SentimentCalumet Specialty Products Partners, L.P has received 62.89% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Calumet Specialty Products Partners, L.P and other stocks. Vote “Outperform” if you believe CLMT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CLMT will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.8 Dividend Strength Dividend YieldCalumet Specialty Products Partners, L.P does not currently pay a dividend.Dividend GrowthCalumet Specialty Products Partners, L.P has been increasing its dividend for 9 years. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Calumet Specialty Products Partners, L.P insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.75% of the stock of Calumet Specialty Products Partners, L.P is held by insiders.Percentage Held by InstitutionsOnly 15.33% of the stock of Calumet Specialty Products Partners, L.P is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Calumet Specialty Products Partners, L.P are expected to grow in the coming year, from ($1.09) to ($0.27) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Calumet Specialty Products Partners, L.P is -2.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Calumet Specialty Products Partners, L.P is -2.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCalumet Specialty Products Partners, L.P has a P/B Ratio of 17.75. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 1.0Community Rank: 1.9Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.87 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Petroleum refining Sub-IndustryN/A SectorOils/Energy Current SymbolNASDAQ:CLMT Previous Symbol CUSIPN/A CIK1340122 Webwww.calumetspecialty.com Phone317-328-5660Debt Debt-to-Equity Ratio129.43 Current Ratio1.24 Quick Ratio0.74Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$3.45 billion Price / Sales0.05 Cash Flow$1.17 per share Price / Cash Flow1.93 Book Value$0.12 per share Price / Book18.83Profitability EPS (Most Recent Fiscal Year)($0.55) Net Income$-43,600,000.00 Net Margins-2.26% Return on Equity-107.75% Return on Assets-1.45%Miscellaneous Employees1,500 Outstanding Shares77,960,000Market Cap$176.19 million Next Earnings Date8/13/2020 (Estimated) OptionableOptionable NASDAQ:CLMT Rates by TradingView Receive CLMT News and Ratings via Email Sign-up to receive the latest news and ratings for CLMT and its competitors with MarketBeat's FREE daily newsletter. Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) Frequently Asked Questions How has Calumet Specialty Products Partners, L.P's stock been impacted by COVID-19 (Coronavirus)? Calumet Specialty Products Partners, L.P's stock was trading at $2.23 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CLMT shares have decreased by 4.5% and is now trading at $2.13. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Calumet Specialty Products Partners, L.P? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Calumet Specialty Products Partners, L.P in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Calumet Specialty Products Partners, L.P. When is Calumet Specialty Products Partners, L.P's next earnings date? Calumet Specialty Products Partners, L.P is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Calumet Specialty Products Partners, L.P. How were Calumet Specialty Products Partners, L.P's earnings last quarter? Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) released its quarterly earnings results on Thursday, May, 7th. The oil and gas company reported $0.28 EPS for the quarter, beating the consensus estimate of ($0.17) by $0.45. The oil and gas company had revenue of $692.60 million for the quarter, compared to analysts' expectations of $785.30 million. Calumet Specialty Products Partners, L.P had a negative net margin of 2.26% and a negative return on equity of 107.75%. View Calumet Specialty Products Partners, L.P's earnings history. What price target have analysts set for CLMT? 2 brokers have issued 1 year price objectives for Calumet Specialty Products Partners, L.P's shares. Their forecasts range from $1.00 to $1.00. On average, they anticipate Calumet Specialty Products Partners, L.P's stock price to reach $1.00 in the next year. This suggests that the stock has a possible downside of 53.1%. View analysts' price targets for Calumet Specialty Products Partners, L.P. Has Calumet Specialty Products Partners, L.P been receiving favorable news coverage? Media coverage about CLMT stock has trended negative this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Calumet Specialty Products Partners, L.P earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned news articles about the oil and gas company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about Calumet Specialty Products Partners, L.P. Are investors shorting Calumet Specialty Products Partners, L.P? Calumet Specialty Products Partners, L.P saw a decrease in short interest during the month of June. As of June 30th, there was short interest totaling 668,200 shares, a decrease of 13.4% from the June 15th total of 771,600 shares. Based on an average daily volume of 293,400 shares, the days-to-cover ratio is presently 2.3 days. Currently, 1.1% of the shares of the company are sold short. View Calumet Specialty Products Partners, L.P's Current Options Chain. Who are some of Calumet Specialty Products Partners, L.P's key competitors? Some companies that are related to Calumet Specialty Products Partners, L.P include Exxon Mobil (XOM), Chevron (CVX), Royal Dutch Shell (RDS.B), BP (BP), China Petroleum & Chemical (SNP), Equinor ASA (EQNR), ConocoPhillips (COP), Phillips 66 (PSX), Suncor Energy (SU), Marathon Petroleum (MPC), Valero Energy (VLO), Hess (HES), Repsol (REPYY), HollyFrontier (HFC) and YPF (YPF). View all competitors. What other stocks do shareholders of Calumet Specialty Products Partners, L.P own? Based on aggregate information from My MarketBeat watchlists, some companies that other Calumet Specialty Products Partners, L.P investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Two Harbors Investment (TWO), Blackrock Capital Investment (BKCC), Novocure (NVCR), Summit Midstream Partners (SMLP), Viper Energy Partners (VNOM), Washington Prime Group (WPG), Roper Technologies (ROP) and New Residential Investment (NRZ). Who are Calumet Specialty Products Partners, L.P's key executives? Calumet Specialty Products Partners, L.P's management team includes the following people: Mr. Timothy Go, Chief Exec. Officer of Calumet GP, LLC (Age 52)Mr. F. William Grube, Exec. Vice Chairman of Calumet GP, LLC (Age 71)Mr. David West Griffin, Exec. VP & CFO of Calumet GP, LLC (Age 58)Mr. William A. Anderson, Exec. VP of Sales - Calumet GP LLC (Age 51)Mr. Bruce A. Fleming, Exec. VP of Strategy & Growth - Calumet GP, LLC (Age 62) What is Calumet Specialty Products Partners, L.P's stock symbol? Calumet Specialty Products Partners, L.P trades on the NASDAQ under the ticker symbol "CLMT." How do I buy shares of Calumet Specialty Products Partners, L.P? Shares of CLMT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Calumet Specialty Products Partners, L.P's stock price today? One share of CLMT stock can currently be purchased for approximately $2.13. How big of a company is Calumet Specialty Products Partners, L.P? Calumet Specialty Products Partners, L.P has a market capitalization of $166.05 million and generates $3.45 billion in revenue each year. The oil and gas company earns $-43,600,000.00 in net income (profit) each year or ($0.55) on an earnings per share basis. Calumet Specialty Products Partners, L.P employs 1,500 workers across the globe. What is Calumet Specialty Products Partners, L.P's official website? The official website for Calumet Specialty Products Partners, L.P is www.calumetspecialty.com. How can I contact Calumet Specialty Products Partners, L.P? Calumet Specialty Products Partners, L.P's mailing address is 2780 WATERFRONT PARKWAY EAST DRIVE SUITE 200, INDIANAPOLIS IN, 46214. The oil and gas company can be reached via phone at 317-328-5660 or via email at [email protected] This page was last updated on 7/6/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
